The KCNH2 genetic polymorphism (1956, C>T) is a novel biomarker that is associated with CCB and α,β-ADR blocker response in EH patients in China.

PLoS One · 2013 · PMC3632552 · PMID 23613831

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

marginally significantP = 0.060so close (0.05 < p ≤ 0.1)

Significant difference in SBP change followed by age, BMI and Bonferroni correction was observed at the end of 2 weeks (genotype*gender, P = 0.028), and a marginally significant difference in MAP change at the end of 6 weeks was also observed (genotype*gender, P = 0.060).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.